Harbin Medisan Pharmaceutical Co., Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 342.15 million compared to CNY 256.69 million a year ago. Net income was CNY 39.16 million compared to net loss of CNY 1.17 million a year ago.